Details for New Drug Application (NDA): 208632
✉ Email this page to a colleague
NDA 208632 describes CLOMIPRAMINE HYDROCHLORIDE, which is a drug marketed by Ajanta Pharma Ltd, Alembic, Amneal Pharms Co, Aurobindo Pharma, Chartwell Rx, Ixora Lifescience, Jubilant Cadista, Lupin Ltd, Mankind Pharma, Micro Labs, Pharmobedient, Rk Pharma, Sandoz, Taro, Teva, Tp Anda Holdings, Unique, Watson Labs, and Zydus Pharms, and is included in twenty-one NDAs. It is available from sixteen suppliers. Additional details are available on the CLOMIPRAMINE HYDROCHLORIDE profile page.
The generic ingredient in CLOMIPRAMINE HYDROCHLORIDE is clomipramine hydrochloride. There are eleven drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the clomipramine hydrochloride profile page.
The generic ingredient in CLOMIPRAMINE HYDROCHLORIDE is clomipramine hydrochloride. There are eleven drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the clomipramine hydrochloride profile page.
Summary for 208632
| Tradename: | CLOMIPRAMINE HYDROCHLORIDE |
| Applicant: | Amneal Pharms Co |
| Ingredient: | clomipramine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 208632
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 25MG | ||||
| Approval Date: | Oct 31, 2018 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 50MG | ||||
| Approval Date: | Oct 31, 2018 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 75MG | ||||
| Approval Date: | Oct 31, 2018 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
